Psilocybin Treatment for Depression

Psychedelic therapy for depression still effective one year later

New research published in the Journal of Psychopharmacology has offered valuable insights into the long-term effects of psilocybin-assisted psychotherapy for depression. The study reports more than half the original cohort were still in remission 12 months after the acute psychedelic treatment.

Source: New Atlas

Scientific American

Johns Hopkins Scientists Give Psychedelics the Serious Treatment

Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look. Scientists are rediscovering what many see as the substances’ astonishing therapeutic potential for a vast range of issues, from depression to drug addiction and acceptance of mortality.

Source: Scientific American


Psilocybin: Magic mushroom compound 'promising' for depression

Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression as conventional treatment, a small, early-stage study has suggested.

Source: BBC

Yale News

Psychedelic spurs growth of neural connections lost in depression

In a new study, Yale researchers show that a single dose of psilocybin given to mice prompted an immediate and long-lasting increase in connections between neurons. The findings are published July 5 in the journal Neuron.

Source: Yale News


How ecstasy and psilocybin are shaking up psychiatry

Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.

Source: Nature


Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac

Psilocybin, the active ingredient in ‘magic mushrooms,’ is now undergoing clinical trials. If all goes well, treatments could be available by 2024.

Source: Newsweek